Synthesis and biological evaluation of 6',7'-dihydroxybergamottin (6,7-DHB), a naturally occurring inhibitor of cytochrome P450 3A4

被引：18
|
作者：
Bellevue, FH
Woster, PM
Edwards, DJ
He, K
Hollenberg, PF
机构：
[1] WAYNE STATE UNIV, DEPT PHARMACEUT SCI, DETROIT, MI 48202 USA
[2] WAYNE STATE UNIV, DEPT PHARM PRACTICE, DETROIT, MI 48202 USA
[3] UNIV MICHIGAN, DEPT PHARMACOL, ANN ARBOR, MI 49109 USA
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1997年 / 7卷 / 20期
关键词：
D O I：
10.1016/S0960-894X(97)10043-9
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
The recently isolated inhibitor of cytochrome P450 CYP3A4, 6',7'-dihydroxybergamottin (6,7-DHB), was synthesized by an efficient route that is readily adaptable to the production of analogues. The compound was evaluated as an inhibitor of 3A4 in a purified enzyme preparation, as well as against human liver microsomes and human 3A4 expressed in Escherichia coli membrane. In each case, 6,7-DHB proved to be a potent NADPH-and time dependent inactivator of 3A4. (C) 1997 Elsevier Science Ltd.
引用
收藏
页码：2593 / 2598
页数：6
相关论文
共 50 条
  • [21] Cytochrome P450 2D6 and 3A4 enzyme inhibition by amine stimulants in dietary supplements
    Liu, Yitong
    Santillo, Michael F.
    DRUG TESTING AND ANALYSIS, 2016, 8 (3-4) : 307 - 310
  • [22] Evaluation of the contribution of cytochrome P450 3A4 to human liver microsomal bupropion hydroxylation
    Faucette, SR
    Hawke, RL
    Shord, SS
    Lecluyse, EL
    Lindley, CM
    DRUG METABOLISM AND DISPOSITION, 2001, 29 (08) : 1123 - 1129
  • [23] Modulation of erlotinib pharmacokinetics in mice by a novel cytochrome P450 3A4 inhibitor, BAS 100
    Smith, N. F.
    Baker, S. D.
    Gonzalez, F. J.
    Harris, J. W.
    Figg, W. D.
    Sparreboom, A.
    BRITISH JOURNAL OF CANCER, 2008, 98 (10) : 1630 - 1632
  • [24] Modulation of erlotinib pharmacokinetics in mice by a novel cytochrome P450 3A4 inhibitor, BAS 100
    N F Smith
    S D Baker
    F J Gonzalez
    J W Harris
    W D Figg
    A Sparreboom
    British Journal of Cancer, 2008, 98 : 1630 - 1632
  • [25] The effect of cyclophosphamide with and without dexamethasone on cytochrome P450 3A4 and 2B6 in human hepatocytes
    Lindley, C
    Hamilton, G
    McCune, JS
    Faucette, S
    Shord, SS
    Hawke, RL
    Wang, HB
    Gilbert, D
    Jolley, S
    Yan, BF
    LeCluyse, EL
    DRUG METABOLISM AND DISPOSITION, 2002, 30 (07) : 814 - 822
  • [26] Evaluation of machine learning models for cytochrome P450 3A4, 2D6, and 2C9 inhibition
    Gong, Changda
    Feng, Yanjun
    Zhu, Jieyu
    Liu, Guixia
    Tang, Yun
    Li, Weihua
    JOURNAL OF APPLIED TOXICOLOGY, 2024, 44 (07) : 1050 - 1066
  • [27] Effects of cytochrome (CYP) p450 3A4 inducers on CYP2B6 catalytic activity.
    Faucette, S
    Lindley, C
    Hawke, R
    Shord, S
    Clarke, M
    LeCluyse, E
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (02) : P10 - P10
  • [28] Pyridine-Substituted Desoxyritonavir Is a More Potent Inhibitor of Cytochrome P450 3A4 than Ritonavir
    Sevrioukova, Irina F.
    Poulos, Thomas L.
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (09) : 3733 - 3741
  • [29] Inhibition of Human Cytochrome P450 Enzymes 3A4 and 2D6 by β-Carboline Alkaloids, Harmine Derivatives
    Zhao, Ting
    He, Yu-qi
    Wang, Jun
    Ding, Ke-min
    Wang, Chang-hong
    Wang, Zheng-tao
    PHYTOTHERAPY RESEARCH, 2011, 25 (11) : 1671 - 1677
  • [30] Cytochrome P450 isozymes 3A4 and 2B6 are involved in the in vitro human metabolism of thiotepa to TEPA
    P. Jacobson
    K. Green
    A. Birnbaum
    R. Remmel
    Cancer Chemotherapy and Pharmacology, 2002, 49 : 461 - 467
12345